Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy

• Published in: Journal of nanobiotechnology Vol. 21; no. 1; pp. 1 - 30
• Main Authors: Liu, Xinyi, Xiao, Chunxiu, Xiao, Kai
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 22.08.2023; BioMed Central; BMC
• Subjects: Animal models; Antibodies; Anticancer properties; Antineoplastic drugs; Antitumor agents; Biocompatibility; Biomedical engineering; Biomimetic nanoparticles; Biomimetics; Cancer; Cancer therapies; Care and treatment; Cell fusion; Clinical trials; Drug carriers; Drug delivery; Drug delivery system; Drug delivery systems; Drugs; Efficiency; Engineering strategy; Extracellular vesicles; Extracellular vesicles (EVs); Forecasts and trends; Functionalization; Genetic engineering; Immune system; Immunogenicity; Magnetic fields; Nanomaterials; Nanoparticles; Nanotechnology; Precision medicine; Proteins; Review; Targeted cancer therapy; Technology application; Toxicity; Tumors; Vesicles; China

Nanotechnology offers the possibility of revolutionizing cancer theranostics in the new era of precision oncology. Extracellular vesicles (EVs)-like biomimetic nanoparticles (EBPs) have recently emerged as a promising platform for targeted cancer drug delivery. Compared with conventional synthetic v...